1. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non antiarrhythmic drugs. Available at: http://www.fda.gov/cder/calendar/meeting/qt4jam.pdf. Accessed March 25, 1997.
2. International Conference on Harmonisation; guidance on E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs; availability. Notice;Food and Drug Administration, HHS;Fed Regist,2005
3. Can pharmacogenetics help rescue drugs withdrawn from the market?;Shah;Pharmacogenomics,2006
4. Drug-induced prolongation of the QT interval;Roden;N Engl J Med,2004
5. Molecularly targeted oncology therapeutics and prolongation of the QT interval;Strevel;J Clin Oncol,2007